Detalhe da pesquisa
1.
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
Blood
; 135(13): 996-1007, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977002
2.
Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years.
Transpl Int
; 35: 10707, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36589262
3.
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Cancer Immunol Immunother
; 69(9): 1751-1766, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335702
4.
Role of interim and end of treatment positron emission tomography for response assessment and prediction of relapse in posttransplant lymphoproliferative disorder.
Acta Oncol
; 58(7): 1041-1047, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31035840
5.
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
Acta Haematol
; 142(4): 197-207, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31163431
6.
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Lancet Oncol
; 19(11): 1449-1458, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348538
7.
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
N Engl J Med
; 372(10): 944-53, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738670
8.
Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases.
Mod Pathol
; 31(9): 1457-1469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765143
9.
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
Haematologica
; 103(8): 1351-1358, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748443
10.
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
Haematologica
; 103(5): 840-848, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29351986
11.
Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
J Magn Reson Imaging
; 48(4): 897-906, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656584
12.
A monocentric retrospective study of 138 therapy-related myeloid neoplasms.
Ann Hematol
; 97(12): 2319-2324, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203335
13.
Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma.
Mod Pathol
; 30(3): 370-381, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28059091
14.
Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study.
Haematologica
; 102(5): 895-902, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183846
15.
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.
Haematologica
; 102(8): 1361-1367, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522574
16.
Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Cancer Immunol Immunother
; 70(4): 1163, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33595726
17.
Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.
Br J Haematol
; 164(2): 258-65, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24219359
18.
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
Blood
; 120(24): 4706-11, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23047822
19.
Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study.
Ann Hematol
; 93(3): 411-24, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23963412
20.
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma.
Br J Haematol
; 163(3): 334-42, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24032456